Intact Therapeutics

Palo Alto, United States

Intact Therapeutics is a makers of smart gels for local drug delivery for gastrointestinal diseases.

Nov 2021

Series A

Biopharma Health Care Therapeutics

Top Investors

Y CombinatorNational Science FoundationNewchip AcceleratorBrightstone Venture CapitalSmart Launch Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Intact Therapeutics

Who are Intact Therapeutics's investors?

Intact Therapeutics's investors include Y Combinator, National Science Foundation, Newchip Accelerator, Brightstone Venture Capital, Smart Launch Ventures.

Where is Intact Therapeutics headquartered?

Intact Therapeutics is headquartered in Palo Alto, United States.

What does Intact Therapeutics do?

Intact Therapeutics is a makers of smart gels for local drug delivery for gastrointestinal diseases.

What stage is Intact Therapeutics at?

Intact Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 17, 2021.

MLA

"Intact Therapeutics — Funding & Investors." VCBacked, November 17, 2021, https://www.vcbacked.co/company/intact-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2021). Intact Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/intact-therapeutics

Wikipedia (cite web)

{{cite web |title=Intact Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/intact-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 17, 2021.